Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Molecular Pharmacology|February 9, 2007
Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3J Robert Lane, Ben Powney, Alan Wise, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2008
G protein coupling and ligand selectivity of the D2L and D3 dopamine receptorsJ Robert Lane, Ben Powney, Alan Wise, et al.
Molecular Pharmacology|August 28, 2004
Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interactionPaul J Brighton, Philip G Szekeres, Alan Wise, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 9, 2008
Paradoxical behavior of neuromedin U in isolated smooth muscle cells and intact tissuePaul J Brighton, Alan Wise, Narinder B Dass, et al.
Oncotarget|August 11, 2015
A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line modelsChrysi Xintaropoulou, Carol Ward, Alan Wise, et al.
Pharmacological Reviews|April 2, 2011
International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B)Stefan Offermanns, Steven L Colletti, Timothy W Lovenberg, et al.
Biochemical and Biophysical Research Communications|September 11, 2004
Ectopically expressed gamma-aminobutyric acid receptor B is functionally down-regulated in isolated lipid raft-enriched membranesAnja Becher, Andrew Green, Antoinette O Ige, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 18, 2008
Antibodies that identify only the active conformation of G(i) family G protein alpha subunitsJ Robert Lane, David Henderson, Ben Powney, et al.
European Journal of Immunology|April 3, 2003
Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signalingBritta Settmacher, Claudia Rheinheimer, Henning Hamacher, et al.
BMC Cancer|June 6, 2018
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatmentChrysi Xintaropoulou, Carol Ward, Alan Wise, et al.
Pageof 3